Projects funded by the NCN

Modulation of mitochondrial calcium traffic in pink1 mutant Zebrafish model of Parkinson's disease

Call: SONATA 8 , Panel: NZ3

Principal investigator: dr Smijin Soman

Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

Effect of various types of acute exercise and exercise trening on NO/sGC/cGMP pathway and death of dopaminergic neurons ...

Call: OPUS 1 , Panel: NZ5

Principal investigator: prof. Małgorzata Chalimoniuk

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

The role of sphingosine-1-phosphate (S1P) receptors signaling in animal model of Parkinson disease. Searching of novel t...

Call: PRELUDIUM 5 , Panel: NZ4

Principal investigator: Joanna Motyl

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

The involvement of P2 purinergic receptors in alpha-synuclein mediated mitochondrial dysfunction. Relevance to Parkinson...

Call: SONATA 5 , Panel: NZ3

Principal investigator: dr Anna Wilkaniec

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Contribution of nitrergic transmission in the modulation of L-dopa activity in the rat 6-OHDA model of Parkinson's disea...

Call: OPUS 1 , Panel: NZ4

Principal investigator: dr hab. Elżbieta Lorenc-Koci

Instytut Farmakologii PAN

The research of molecular markers for neuroprotective effect of tetrahydroisoquinolines based on various eksperimental m...

Call: OPUS 4 , Panel: NZ7

Principal investigator: dr Agnieszka Wąsik

Instytut Farmakologii PAN

Influence of music therapy to improve quality of gait and selected daily live activities in a group of patients with Par...

Call: PRELUDIUM 3 , Panel: NZ7

Principal investigator: Anna Bukowska

Akademia Wychowania Fizycznego im. Bronisława Czecha w Krakowie, Wydział Rehabilitacji Ruchowej

The role of astrocytes and cellular metabolism in functional compensation of degeneration of dopaminergic system in the ...

Call: OPUS 3 , Panel: NZ4

Principal investigator: dr Katarzyna Kuter

Instytut Farmakologii, Polska Akademia Nauk

The role of Parkin in exogenous Alpha-synuclein-induced cell death. Implications for pathogenesis of Parkinson's disease...

Call: OPUS 3 , Panel: NZ3

Principal investigator: dr hab. Agata Adamczyk

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Interaction between temporal predictability and action control in ADHD and Parkinson's Disease: behavioural, neurophysio...

Call: SONATINA 8 , Panel: HS6

Principal investigator: dr Inga Korolczuk

Uniwersytet Medyczny w Lublinie

Evaluation of P2X7 purinergic receptor as a trigger of brain metabolic abnormalities and neuronal degeneration in a mous...

Call: SONATA BIS 13 , Panel: NZ4

Principal investigator: dr Anna Wilkaniec

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk

How inactivation of Mitochondrial Calcium Uniporter protects dopaminergic neurons

Call: OPUS 25 , Panel: NZ4

Principal investigator: prof. Jacek Kuźnicki

Międzynarodowy Instytut Biologii Molekularnej i Komórkowej w Warszawie

Biological control and pharmacological regulation of RNAs implicated in aetiology of Parkinson's disease

Call: OPUS 25 , Panel: NZ1

Principal investigator: prof. Gracjan Michlewski

Międzynarodowy Instytut Biologii Molekularnej i Komórkowej w Warszawie

The link between circadian clock, light pollution and Parkinson's disease development - research on Drosophila melanogas...

Call: SONATA BIS 12 , Panel: NZ3

Principal investigator: dr Milena Damulewicz

Uniwersytet Jagielloński, Wydział Biologii

Dysfunction of NFE2L1 and other family members causes damage in dopaminergic neuron function through dysregulated transc...

Call: PRELUDIUM 21 , Panel: NZ5

Principal investigator: Kamila Łuczyńska

Instytut Genetyki i Biotechnologii Zwierząt Polskiej Akademii Nauk

Algorithmic estimation of eye movements changes in relation to development of Parkinson's disease

Call: OPUS 2 , Panel: ST6

Principal investigator: dr hab. Andrzej Przybyszewski

Polsko-Japońska Akademia Technik Komputerowych

Small-molecule inhibitors of protein aggregation and ER stress as a novel strategy against neurodegeneration in the cour...

Call: PRELUDIUM BIS 3 , Panel: NZ5

Principal investigator: prof. Ireneusz Majsterek

Uniwersytet Medyczny w Łodzi

New graphene-based approach targeting the prion-like propagation of α-synuclein in Parkinson's disease.

Call: SONATA BIS 11 , Panel: NZ7

Principal investigator: dr hab. Małgorzata Kujawska

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Learned irrelevance in idiopathic Parkinson's disease: searching for a neurochemical basis and implications for patients...

Call: PRELUDIUM 20 , Panel: HS6

Principal investigator: Aleksandra Petryka-Fijałkiewicz

Uniwersytet Jagielloński, Wydział Filozoficzny

Pharmacological evaluation of possible neuroprotective strategies in novel genetic mouse models of progressive neurodege...

Call: OPUS 2 , Panel: NZ7

Principal investigator: dr Grzegorz Kreiner

Instytut Farmakologii PAN

The mechanisms of mitochondrial damage-dependent neuroinflammation in experimental models of Parkinson's disease. The ro...

Call: OPUS 20 (LAP) , Panel: NZ4

Principal investigator: prof. Agata Adamczyk

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk

Analysis of the molecular mechanism of phosphorylated α-synuclein and ubiquitinated protein accumulation caused by dopam...

Call: PRELUDIUM BIS 2 , Panel: NZ5

Principal investigator: dr Hiroaki Taniguchi

Instytut Genetyki i Biotechnologii Zwierząt Polskiej Akademii Nauk

Regulation of microRNAs for the treatment and understanding the etiology of Parkinson's disease

Call: Polskie Powroty NAWA 2020 , Panel: NZ1

Principal investigator: dr hab. Gracjan Patryk Michlewski

Międzynarodowy Instytut Biologii Molekularnej i Komórkowej w Warszawie

Spatial analysis of the effects of L-DOPA on gene expression in the prefrontal cortex in a mouse model of Parkinson's di...

Call: PRELUDIUM 19 , Panel: NZ4

Principal investigator: Anna Radlicka

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

In vivo effects, underlying signaling pathways and mechanism of action of ghrelin receptor agonist against pathological ...

Call: SONATA 15 , Panel: NZ7

Principal investigator: dr Piotr Chmielarz

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Physical exercise as a natural mechanism inducing neuroregeneration. Search for the new protein markers and therapeutic ...

Call: OPUS 18 , Panel: NZ7

Principal investigator: dr hab. Katarzyna Kuter

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Involvement of astrocytes in the neuroprotective mechanism evoked by enhancement of noradrenergic transmission in trasng...

Call: PRELUDIUM 18 , Panel: NZ7

Principal investigator: Justyna Barut

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Effect of drugs, mitochondrial proteins and miRNA biomarkers of neurodegenerative diseases on dynamics and conversion of...

Call: SONATA BIS 9 , Panel: ST4

Principal investigator: dr hab. Sławomir Jakieła

Szkoła Główna Gospodarstwa Wiejskiego w Warszawie

Frontal lobes characteristic symptoms in Parkinson's disease.

Call: PRELUDIUM 17 , Panel: HS6

Principal investigator: Paulina Golińska

Uniwersytet Gdański, Wydział Nauk Społecznych

The importance of the crosstalk between alpha-synuclein and sphingosine-1-phosphate-dependent signalling in experimental...

Call: SONATINA 3 , Panel: NZ4

Principal investigator: dr Joanna Motyl

Instytut Biocybernetyki i Inżynierii Biomedycznej im. Macieja Nałęcza Polskiej Akademii Nauk

Prolonged high intensity interval training (HIIT) modulates inflammation through the specific microRNAs level changes in...

Call: PRELUDIUM 16 , Panel: NZ7

Principal investigator: Paulina Małczyńska-Sims

Instytut Psychiatrii i Neurologii

The role of circadian clock, Nrf2 transcription factor and haeme oxygenase in the regulation of innate immune responses....

Call: OPUS 15 , Panel: NZ3

Principal investigator: prof. Elżbieta Pyza

Uniwersytet Jagielloński, Wydział Biologii

Urolithin A as a metabolite of ellagitannins with potential neuroprotective activity - the research of mechanisms of thi...

Call: SONATA 13 , Panel: NZ7

Principal investigator: dr Małgorzata Kujawska

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Evaluation of the influence of progressive noradrenergic neurodegeneration on dopaminergic system functioning in context...

Call: OPUS 13 , Panel: NZ7

Principal investigator: dr Grzegorz Kreiner

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Effect of high intensity interval training on mechanisms of neuroplasticity and psychomotor behaviours in Parkinson's di...

Call: OPUS 13 , Panel: NZ7

Principal investigator: dr hab. Jarosław Marusiak

Akademia Wychowania Fizycznego we Wrocławiu, Wydział Fizjoterapii

New mulitple target-directed ligands - A1/A2A adenosine receptors antagonists and monoamine oxidase B inhibitors - searc...

Call: PRELUDIUM 12 , Panel: NZ7

Principal investigator: Michał Załuski

Uniwersytet Jagielloński, Collegium Medicum, Wydział Farmaceutyczny

Counteraction Parkinson's disease by application of progressive vibration training in humans and evaluation of factors w...

Call: SONATA 1 , Panel: NZ7

Principal investigator: dr Anna Gąsiorowska

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Znaczenie kinazy sfingozyny 1 oraz sfingozyno-1-fosforanu w doświadczalnym modelu choroby Parkinsona oraz w farmakologic...

Call: ETIUDA 4 , Panel: NZ3

Principal investigator: Joanna Motyl

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk

Dissecting pathomechanisms of idiopathic form of Parkinson's Disease using induced pluripotent stem cells technology

Call: OPUS 9 , Panel: NZ5

Principal investigator: prof. Marcin Majka

Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Lekarski